Phase 3 Amyotrophic Lateral Sclerosis Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Recruiting
Phase 2Phase 3
HEALEY ALS Platform Trial - Master Protocol
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD1,500 enrolled78 locationsNCT04297683
Recruiting
Phase 3
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Amyotrophic Lateral Sclerosis
Prilenia500 enrolled5 locationsNCT07322003
Recruiting
Phase 2Phase 3
Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS
Amyotrophic Lateral Sclerosis
Mario Negri Institute for Pharmacological Research246 enrolled19 locationsNCT06126315
Recruiting
Phase 3
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Amyotrophic Lateral Sclerosis
AB Science495 enrolled56 locationsNCT03127267
Recruiting
Phase 2Phase 3
RAPA-501 Therapy for ALS
Amyotrophic Lateral Sclerosis
Rapa Therapeutics LLC41 enrolled1 locationNCT04220190
Recruiting
Phase 3
Platform Trial to Assess the Efficacy of Multiple Drugs in Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis
Stichting TRICALS Foundation171 enrolled13 locationsNCT06008249